Trial · NCT03390504
Participant flow16
How many started, completed or left each group, period by period.
1 to 16 of 16
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Cohort 1: Arm 1A: Erdafitinib 8 mg/9 mg | 143 | |
| Overall Study | STARTED | Cohort 1: Arm 1B: Chemotherapy (Vinflunine 320 mg/m^2 or Docetaxel 75 mg/m^2) | 135 | |
| Overall Study | STARTED | Cohort 2: Arm 2A: Erdafitinib 8 mg/ 9 mg | 175 | |
| Overall Study | STARTED | Cohort 2: Arm 2B: Pembrolizumab 200 mg | 176 | |
| Overall Study | Treated | Cohort 1: Arm 1A: Erdafitinib 8 mg/9 mg | 142 | |
| Overall Study | Treated | Cohort 1: Arm 1B: Chemotherapy (Vinflunine 320 mg/m^2 or Docetaxel 75 mg/m^2) | 117 | |
| Overall Study | Treated | Cohort 2: Arm 2A: Erdafitinib 8 mg/ 9 mg | 173 | |
| Overall Study | Treated | Cohort 2: Arm 2B: Pembrolizumab 200 mg | 173 | |
| Overall Study | COMPLETED | Cohort 1: Arm 1A: Erdafitinib 8 mg/9 mg | 137 | |
| Overall Study | COMPLETED | Cohort 1: Arm 1B: Chemotherapy (Vinflunine 320 mg/m^2 or Docetaxel 75 mg/m^2) | 114 | |
| Overall Study | COMPLETED | Cohort 2: Arm 2A: Erdafitinib 8 mg/ 9 mg | 168 | |
| Overall Study | COMPLETED | Cohort 2: Arm 2B: Pembrolizumab 200 mg | 167 | |
| Overall Study | NOT COMPLETED | Cohort 1: Arm 1A: Erdafitinib 8 mg/9 mg | 6 | |
| Overall Study | NOT COMPLETED | Cohort 1: Arm 1B: Chemotherapy (Vinflunine 320 mg/m^2 or Docetaxel 75 mg/m^2) | 21 | |
| Overall Study | NOT COMPLETED | Cohort 2: Arm 2A: Erdafitinib 8 mg/ 9 mg | 7 | |
| Overall Study | NOT COMPLETED | Cohort 2: Arm 2B: Pembrolizumab 200 mg | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03390504/flow